Viral bronchitis
Pro Research Analysisby 
Searched over 200M research papers for "viral bronchitis"
Consensus Meter
Viral Bronchitis: An Overview
Introduction to Viral Bronchitis in Infants
Viral bronchitis, often referred to as bronchiolitis in infants, is a prevalent lower respiratory tract infection primarily affecting children under two years of age. This condition is characterized by inflammation and obstruction of the lower airways, leading to significant morbidity and healthcare costs .
Common Viral Pathogens in Bronchiolitis
Respiratory Syncytial Virus (RSV)
Respiratory Syncytial Virus (RSV) is the most common cause of viral bronchiolitis in young children. Identified in 1955, RSV remains the leading pathogen responsible for this condition . RSV bronchiolitis is particularly severe and often necessitates hospitalization.
Other Viral Agents
In addition to RSV, other viruses such as rhinovirus, adenovirus, metapneumovirus, and bocavirus have been implicated in the etiology of bronchiolitis. However, the severity of the disease does not consistently correlate with the type of virus detected .
Clinical Features and Diagnosis
Clinical Presentation
The diagnosis of viral bronchiolitis is primarily clinical, characterized by symptoms of a viral upper respiratory infection that progresses to the lower respiratory tract. Common symptoms include coughing, wheezing, and difficulty breathing .
Diagnostic Testing
While viral testing can identify the specific pathogen, it is generally not necessary for the clinical management of bronchiolitis. Diagnostic testing is mainly useful for cohort and quarantine purposes in hospital settings.
Treatment and Management
Supportive Care
The cornerstone of bronchiolitis management is supportive care, focusing on maintaining adequate oxygenation and hydration. Oxygen supplementation is recommended in the presence of hypoxemia, and noninvasive or invasive ventilatory support may be required for severe cases .
Pharmacologic Interventions
Current evidence does not support the routine use of bronchodilators, corticosteroids, or nebulized racemic epinephrine in the treatment of bronchiolitis. These treatments have not shown significant benefits in reducing hospital admissions or the length of hospital stay .
Emerging Treatments
The use of hypertonic saline is an evolving area of research, but its efficacy is not yet clearly defined. Passive immunoprophylaxis with a monoclonal antibody against RSV has shown effectiveness in preventing severe RSV bronchiolitis in high-risk infants, such as those born prematurely or with chronic lung disease .
Long-term Implications
Risk of Asthma
Infants who experience severe bronchiolitis, particularly those requiring hospitalization, are at an increased risk of developing recurrent wheezing and asthma later in childhood. This association is observed with both RSV and rhinovirus infections .
Genetic and Environmental Factors
The development of asthma following bronchiolitis may be influenced by genetic susceptibility and environmental factors. Further research is needed to clarify whether severe lower respiratory tract infections cause asthma or if preexisting conditions predispose infants to severe infections .
Conclusion
Viral bronchiolitis is a significant health concern in infants, primarily caused by RSV and other respiratory viruses. The management of this condition is largely supportive, with limited roles for pharmacologic treatments. Understanding the long-term implications, such as the increased risk of asthma, is crucial for developing preventive strategies and improving patient outcomes. Further research is essential to enhance our understanding and management of viral bronchiolitis in young children.
Sources and full results
Most relevant research papers on this topic